These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38878861)

  • 1. Type 2 Inflammation and Asthma in Children: A Narrative Review.
    Papadopoulos NG; Bacharier LB; Jackson DJ; Deschildre A; Phipatanakul W; Szefler SJ; Gall R; Ledanois O; Jacob-Nara JA; Sacks H
    J Allergy Clin Immunol Pract; 2024 Sep; 12(9):2310-2324. PubMed ID: 38878861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled nitric oxide: a test for diagnosis and control of asthma?
    Katial R; Stewart L
    Curr Allergy Asthma Rep; 2007 Nov; 7(6):459-63. PubMed ID: 17986377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different endotypes and phenotypes drive the heterogeneity in severe asthma.
    McDowell PJ; Heaney LG
    Allergy; 2020 Feb; 75(2):302-310. PubMed ID: 31267562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype.
    Rabe KF; FitzGerald JM; Bateman ED; Castro M; Pavord ID; Maspero JF; Busse WW; Izuhara K; Daizadeh N; Ortiz B; Pandit-Abid N; Rowe PJ; Deniz Y
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2916-2924.e4. PubMed ID: 36028446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human asthma phenotypes: from the clinic, to cytokines, and back again.
    Bhakta NR; Woodruff PG
    Immunol Rev; 2011 Jul; 242(1):220-32. PubMed ID: 21682748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids.
    Yin SS; Liu H; Gao X
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional Exhaled Nitric Oxide Monitoring Does Not Improve Asthma Management in Children with Concordant and Discordant Asthma Phenotypes.
    Voorend-van Bergen S; Vaessen-Verberne AA; Landstra AM; Brackel HJ; van den Berg NJ; Merkus PJ; de Jongste JC; Pijnenburg MW
    Am J Respir Crit Care Med; 2015 Oct; 192(8):1016-8. PubMed ID: 26469843
    [No Abstract]   [Full Text] [Related]  

  • 8. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal risk factors for asthma exacerbations among inner-city children.
    Teach SJ; Gergen PJ; Szefler SJ; Mitchell HE; Calatroni A; Wildfire J; Bloomberg GR; Kercsmar CM; Liu AH; Makhija MM; Matsui E; Morgan W; O'Connor G; Busse WW
    J Allergy Clin Immunol; 2015 Jun; 135(6):1465-73.e5. PubMed ID: 25794658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma.
    Bacharier LB; Pavord ID; Maspero JF; Jackson DJ; Fiocchi AG; Mao X; Jacob-Nara JA; Deniz Y; Laws E; Mannent LP; Amin N; Akinlade B; Staudinger HW; Lederer DJ; Hardin M
    J Allergy Clin Immunol; 2024 Jul; 154(1):101-110. PubMed ID: 38272375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Diagnosis Techniques in Pediatric Asthma: Impulse Oscillometry in Preschool Asthma and Use of Exhaled Nitric Oxide.
    McDowell KM
    Immunol Allergy Clin North Am; 2019 May; 39(2):205-219. PubMed ID: 30954171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled nitric oxide in childhood allergic asthma management: a randomised controlled trial.
    Peirsman EJ; Carvelli TJ; Hage PY; Hanssens LS; Pattyn L; Raes MM; Sauer KA; Vermeulen F; Desager KN
    Pediatr Pulmonol; 2014 Jul; 49(7):624-31. PubMed ID: 24039119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.
    Chipps BE; Newbold P; Hirsch I; Trudo F; Goldman M
    Ann Allergy Asthma Immunol; 2018 May; 120(5):504-511.e4. PubMed ID: 29409951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe asthma: When to resort to biological agents.
    Tenero L; Rossignoli S; Piacentini G
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():37-39. PubMed ID: 32017206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
    Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID;
    Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhaled corticosteroids on bronchial asthma in Japanese athletes.
    Hoshino Y; Koya T; Kagamu H; Tsukioka K; Toyama M; Sakagami T; Hasegawa T; Narita I; Arakawa M; Suzuki E
    Allergol Int; 2015 Apr; 64(2):145-9. PubMed ID: 25838089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting asthma morbidity in children using proposed markers of Th2-type inflammation.
    Konradsen JR; Skantz E; Nordlund B; Lidegran M; James A; Ono J; Ohta S; Izuhara K; Dahlén SE; Alving K; Hedlin G
    Pediatr Allergy Immunol; 2015 Dec; 26(8):772-9. PubMed ID: 26266838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma.
    Kupryś-Lipińska I; Molińska K; Kuna P
    Pneumonol Alergol Pol; 2016; 84(4):232-43. PubMed ID: 27435350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab in patients with uncontrolled asthma: type 2 biomarkers might be predictors of therapeutic efficacy.
    Yang D; Huang T; Liu B; Du Z; Liu C
    J Asthma; 2020 Jan; 57(1):79-81. PubMed ID: 30821528
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of corticosteroid response in pediatric patients with severe asthma by using a multidomain approach.
    Bossley CJ; Fleming L; Ullmann N; Gupta A; Adams A; Nagakumar P; Bush A; Saglani S
    J Allergy Clin Immunol; 2016 Aug; 138(2):413-420.e6. PubMed ID: 27061250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.